title: Attenuation of ischemic liver injury by a non-selective endothelin receptor antagonist.
authors.affiliation: Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pennsylvania, USA.
authors.forename: M B
authors.initials: MB
authors.lastname: Jin
authors.forename: Y
authors.initials: Y
authors.lastname: Zhu
authors.forename: S
authors.initials: S
authors.lastname: Zhang
authors.forename: N
authors.initials: N
authors.lastname: Ishizaki
authors.forename: H
authors.initials: H
authors.lastname: Tanaka
authors.forename: V M
authors.initials: VM
authors.lastname: Subbotin
authors.forename: R G
authors.initials: RG
authors.lastname: Lee
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
authors.forename: S
authors.initials: S
authors.lastname: Todo
mesh_terms: D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D001647:Bile Acids and Salts / Q000097:blood; D004285:Dogs; D065128:Endothelin Receptor Antagonists; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D007511:Ischemia / Q000473:pathology; D008099:Liver / Q000098:blood supply* / Q000473:pathology / Q000503:physiopathology; D010456:Peptides, Cyclic / Q000494:pharmacology*; D015427:Reperfusion Injury / Q000517:prevention & control*
chemical_list: D001647:Bile Acids and Salts; D065128:Endothelin Receptor Antagonists; D010456:Peptides, Cyclic; C088196:TAK 044; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase